The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The CYP2C19 rs4917623 single nucleotide polymorphism to predict tamoxifen efficacy in estrogen receptor-positive breast cancer patients.
 
Nobuyasu Yoshimoto
No Relationships to Disclose
 
Akihiro Naito
No Relationships to Disclose
 
Nobuko Kawaguchi
No Relationships to Disclose
 
Miwa Kato
No Relationships to Disclose
 
Naoto Kondo
No Relationships to Disclose
 
Yumi Wanifuchi-Endo
No Relationships to Disclose
 
Tatsuya Toyama
Consulting or Advisory Role - AstraZeneca; Lilly
Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai; Kyowa Hakko Kirin; Lilly; Nippon Kayaku; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Nippon Kayaku (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)